annual EBITDA:
$80.06M+$104.84M(+423.00%)Summary
- As of today (June 22, 2025), EVH annual EBITDA is $80.06 million, with the most recent change of +$104.84 million (+423.00%) on December 31, 2024.
- During the last 3 years, EVH annual EBITDA has risen by +$24.39 million (+43.83%).
- EVH annual EBITDA is now -77.16% below its all-time high of $350.45 million, reached on December 31, 2015.
Performance
EVH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$28.70M-$40.80M(-337.37%)Summary
- As of today (June 22, 2025), EVH quarterly EBITDA is -$28.70 million, with the most recent change of -$40.80 million (-337.37%) on March 31, 2025.
- Over the past year, EVH quarterly EBITDA has dropped by -$47.49 million (-252.81%).
- EVH quarterly EBITDA is now -107.65% below its all-time high of $375.20 million, reached on December 31, 2015.
Performance
EVH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$32.57M-$47.49M(-59.32%)Summary
- As of today (June 22, 2025), EVH TTM EBITDA is $32.57 million, with the most recent change of -$47.49 million (-59.32%) on March 31, 2025.
- Over the past year, EVH TTM EBITDA has dropped by -$7.43 million (-18.59%).
- EVH TTM EBITDA is now -90.71% below its all-time high of $350.45 million, reached on December 31, 2015.
Performance
EVH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EVH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +423.0% | -252.8% | -18.6% |
| 3 y3 years | +43.8% | -317.5% | -43.8% |
| 5 y5 years | +131.4% | +48.6% | +111.7% |
EVH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +423.0% | -177.1% | +37.6% | -59.3% | +181.1% |
| 5 y | 5-year | at high | +131.4% | -177.1% | +84.4% | -59.3% | +107.1% |
| alltime | all time | -77.2% | +131.4% | -107.7% | +85.9% | -90.7% | +107.1% |
EVH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$28.70M(-337.4%) | $32.57M(-59.3%) |
| Dec 2024 | $80.06M(-423.0%) | $12.09M(+1.2%) | $80.06M(+29.7%) |
| Sep 2024 | - | $11.96M(-67.9%) | $61.74M(-6.4%) |
| Jun 2024 | - | $37.22M(+98.2%) | $65.92M(+64.8%) |
| Mar 2024 | - | $18.79M(-401.7%) | $40.00M(-261.4%) |
| Dec 2023 | -$24.79M(-219.8%) | -$6.23M(-138.6%) | -$24.79M(+862.5%) |
| Sep 2023 | - | $16.14M(+42.9%) | -$2.58M(-93.6%) |
| Jun 2023 | - | $11.30M(-124.6%) | -$40.16M(+4.3%) |
| Mar 2023 | - | -$46.00M(-387.8%) | -$38.51M(-286.1%) |
| Dec 2022 | $20.69M(-62.8%) | $15.98M(-174.5%) | $20.69M(-28.2%) |
| Sep 2022 | - | -$21.44M(-265.6%) | $28.83M(-50.9%) |
| Jun 2022 | - | $12.95M(-1.9%) | $58.69M(+1.3%) |
| Mar 2022 | - | $13.20M(-45.3%) | $57.91M(+3.8%) |
| Dec 2021 | $55.66M(-123.1%) | $24.12M(+186.5%) | $55.82M(+24.0%) |
| Sep 2021 | - | $8.42M(-30.8%) | $45.03M(+103.0%) |
| Jun 2021 | - | $12.17M(+9.6%) | $22.19M(-112.8%) |
| Mar 2021 | - | $11.11M(-16.7%) | -$173.84M(-27.8%) |
| Dec 2020 | -$240.74M(-5.4%) | $13.33M(-192.4%) | -$240.74M(-47.5%) |
| Sep 2020 | - | -$14.42M(-92.2%) | -$458.13M(+1.5%) |
| Jun 2020 | - | -$183.85M(+229.5%) | -$451.26M(+61.7%) |
| Mar 2020 | - | -$55.80M(-72.7%) | -$279.00M(+9.6%) |
| Dec 2019 | -$254.52M | -$204.06M(+2603.2%) | -$254.52M(+404.7%) |
| Sep 2019 | - | -$7.55M(-34.9%) | -$50.43M(+14.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$11.59M(-63.0%) | -$44.09M(+38.9%) |
| Mar 2019 | - | -$31.32M(<-9900.0%) | -$31.76M(+664.8%) |
| Dec 2018 | -$4.15M(-89.7%) | $27.00K(-102.2%) | -$4.15M(-60.9%) |
| Sep 2018 | - | -$1.22M(-262.2%) | -$10.61M(-32.2%) |
| Jun 2018 | - | $749.00K(-120.2%) | -$15.64M(-45.9%) |
| Mar 2018 | - | -$3.71M(-42.3%) | -$28.94M(-28.4%) |
| Dec 2017 | -$40.40M(-81.6%) | -$6.43M(+3.0%) | -$40.40M(-34.4%) |
| Sep 2017 | - | -$6.25M(-50.2%) | -$61.56M(-8.9%) |
| Jun 2017 | - | -$12.55M(-17.3%) | -$67.60M(+5.9%) |
| Mar 2017 | - | -$15.18M(-45.0%) | -$63.81M(-71.0%) |
| Dec 2016 | -$220.06M(-162.8%) | -$27.59M(+124.6%) | -$220.06M(-220.4%) |
| Sep 2016 | - | -$12.29M(+40.3%) | $182.73M(+1.1%) |
| Jun 2016 | - | -$8.76M(-94.9%) | $180.82M(+1.0%) |
| Mar 2016 | - | -$171.43M(-145.7%) | $179.03M(-48.9%) |
| Dec 2015 | $350.45M(>+9900.0%) | $375.20M(-2744.1%) | $350.45M(-1516.3%) |
| Sep 2015 | - | -$14.19M(+34.4%) | -$24.75M(+134.4%) |
| Jun 2015 | - | -$10.55M(<-9900.0%) | -$10.55M(<-9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | -$10.99M(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | -$10.99M(0.0%) |
| Jun 2014 | - | $0.00(-100.0%) | -$10.99M(0.0%) |
| Mar 2014 | - | -$10.99M | -$10.99M |
| Dec 2013 | -$19.95M | - | - |
FAQ
- What is Evolent Health annual EBITDA?
- What is the all time high annual EBITDA for Evolent Health?
- What is Evolent Health annual EBITDA year-on-year change?
- What is Evolent Health quarterly EBITDA?
- What is the all time high quarterly EBITDA for Evolent Health?
- What is Evolent Health quarterly EBITDA year-on-year change?
- What is Evolent Health TTM EBITDA?
- What is the all time high TTM EBITDA for Evolent Health?
- What is Evolent Health TTM EBITDA year-on-year change?
What is Evolent Health annual EBITDA?
The current annual EBITDA of EVH is $80.06M
What is the all time high annual EBITDA for Evolent Health?
Evolent Health all-time high annual EBITDA is $350.45M
What is Evolent Health annual EBITDA year-on-year change?
Over the past year, EVH annual EBITDA has changed by +$104.84M (+423.00%)
What is Evolent Health quarterly EBITDA?
The current quarterly EBITDA of EVH is -$28.70M
What is the all time high quarterly EBITDA for Evolent Health?
Evolent Health all-time high quarterly EBITDA is $375.20M
What is Evolent Health quarterly EBITDA year-on-year change?
Over the past year, EVH quarterly EBITDA has changed by -$47.49M (-252.81%)
What is Evolent Health TTM EBITDA?
The current TTM EBITDA of EVH is $32.57M
What is the all time high TTM EBITDA for Evolent Health?
Evolent Health all-time high TTM EBITDA is $350.45M
What is Evolent Health TTM EBITDA year-on-year change?
Over the past year, EVH TTM EBITDA has changed by -$7.43M (-18.59%)